Oxford Close to Find Corona Vaccine

Spread the love

More than 100 candidates are involved in the invention of the corona virus vaccine. But Oxford University has raised the highest expectations for a successful vaccine. This vaccine trial, being led by Professor Sarah Gilbert, achieved great success on Friday. You will be happy to know that you have successfully crossed the first phase of human trials and now the second and third phase is going to start soon. The name of this vaccine is ChAdOx1 nCoV-19.

Sarah Gilbert, a professor of vaccineology, said that she included 1,000 Volunteers, aged between 18 and 55, in the first phase of the human trial. After dividing all these people into two groups, two different vaccines were tested. However, Volunteers was not informed about which vaccine they had been given.

Second Stage of Vaccine Trial

Preparations are now being made for the second and third phases of the vaccine’s human trial. In this first phase, a small number of children between 5 to 12 years, youth and 10,260 people from 56 to 69 years will be included. In this way, researchers will assess the effect of the vaccine in people of different ages.

Phase III of the vaccine trial

In the third phase of the vaccine trial on humans, people above the age of 18 years will be included in even greater numbers. In this, researchers will see how effective this vaccine is for treating corona virus.

In the second and third phases of the vaccine trial, all Volunteers of the group will be given one or two doses of ChAdOx1 nCoV-19 and licensed vaccine MenACWY. This test will be like a ‘blind game’ in which the Volunteers will not be told which vaccine they have been given.

See also  Samsung launches three new programs, customers will get these offers

Earlier too, Sarah Gilbert said that she has great expectations from this trial personally. He also said that if he got success in vaccine trials, the world could get the first vaccine of Corona virus by the month of September.

How did Oxford make the Corona vaccine?

To make the vaccine, scientists first took the spike protein of genes from the surface of the corona virus and injected the prepared vaccine into the body of the person concerned.

After producing antibodies in the body, this vaccine will stimulate the immune system and also activate T-cells in the body, which will act to destroy the infected cells.

Research experts also claim that even if the corona virus attacks the body again, these antibodies and T-cells will protect the body by fighting it.

Leave a Reply

Your email address will not be published. Required fields are marked *